Try our Advanced Search for more refined results
Pennsylvania
-
March 05, 2026
Pharma Co. Investors Secure Class Cert. Over FDA Obstacles
A Pennsylvania federal judge has granted certification to a group of Verrica Pharmaceuticals Inc. investors who claim the company defrauded them by hiding obstacles it faced in obtaining approval from the U.S. Food and Drug Administration for its lead product, though she made a slight change to the class definition to avoid what she called a "heads I win, tails you lose strategy."
-
March 05, 2026
Pennsylvania Man Gets 9¼ Years, $12M Fine For Fraud Scheme
A former Philadelphia-area businessman who admitted bilking millions from investors, business partners, and employees by holding himself out as a successful entrepreneur has been sentenced to 9¼ years in prison and ordered to pay more than $12 million in restitution to his victims.
-
March 05, 2026
Hyundai Faces $9.8M Sanction For Car Destruction
A Pennsylvania court has awarded two car dealerships nearly $9.8 million as a sanction against Hyundai Motor America after finding Hyundai "consciously" crushed cars they acquired before alleging, without evidence, that they intentionally damaged them to exploit Hyundai's vehicle repurchases.
-
March 05, 2026
3rd Circ. Takes Up Cognizant H-1B Fraud FCA Claims
The Third Circuit has agreed to review whether a case brought by a former Cognizant Technology Solutions Corp. executive alleging the company defrauded the government through its visa applications should be tossed, according to a court order.
-
March 05, 2026
Two Dozen States Sue Trump To Halt New Global Tariffs
A coalition of 24 states sued President Donald Trump's administration Thursday in the U.S. Court of International Trade to block global tariffs that the White House imposed shortly after the U.S. Supreme Court struck down an earlier round of tariffs.
-
March 05, 2026
Enviri, Veolia's $3B Clean Earth Deal Gets US Antitrust Nod
Enviri Corp. has disclosed the early termination of the waiting period under the Hart-Scott-Rodino Act for its planned sale of Clean Earth to Veolia Environnement SA for more than $3 billion.
-
March 05, 2026
3rd Circ. Says Macy's Clear To Arbitrate Worker's Bias Suit
The Third Circuit ruled that a white ex-Macy's store manager fired after a shoplifting incident can't pursue his race and sexual orientation discrimination case in court, homing in on a document the department store chain mailed to his home that clearly said disputes would be handled through arbitration.
-
March 04, 2026
Wheeling & Appealing: The Latest Must-Know Appellate Action
If this month's circuit calendars were a March Madness bracket, we'd struggle to pick the top-seeded showdown. Big Pharma against the False Claims Act, or big business against President Donald Trump's visa fees? A big bank's view of "human life wagers," or en banc review in a State Farm class action?
-
March 04, 2026
CVS Beats Antitrust Suit Over 340B Drug Program, For Good
CVS Health Corp. permanently defeated a proposed antitrust class action alleging it forced hospitals in a discount drug program to use its third-party administrator for savings, when a Pennsylvania federal judge ruled Tuesday that hospitals aren't required to contract with CVS and can pick Walgreens or other participating pharmacies to contract with.
-
March 04, 2026
Penn State Gets Vax Refuser's Religious Bias Suit Narrowed
A federal judge permanently cleaved claims Wednesday from a lawsuit alleging Pennsylvania State University's COVID-19 vaccine testing policy for workers who skipped immunizations discriminated against a former employee's evangelical beliefs, ruling the ex-worker's qualms with the policy weren't informed by his religious convictions.
-
March 04, 2026
Zantac Investor Class Action Time-Barred, Pa. Judge Rules
The maker of heartburn and acid reflux relief tablet Zantac has defeated a securities fraud class action claiming the company hid for decades the cancer risks associated with the drug, causing a stock price drop when the truth was revealed, after a Pennsylvania federal judge ruled Wednesday that the claims were untimely.
-
March 04, 2026
Select Medical's $3.9B Deal Is Latest Insider-Led Buyout
Select Medical Holdings Corp. will be taken private in a $3.9 billion deal led by its executive chair, another senior executive, and the private equity firm Welsh Carson Anderson & Stowe, marking the latest in a series of recent insider-led buyouts.
-
March 04, 2026
Sandoz Parent Targets Walmart, Southwest Generic Drug Suits
Sandoz parent company Sandoz AG contested generic drug price-fixing complaints from Southwest Airlines, Walmart, Walgreen and United Healthcare, arguing that the direct action plaintiffs cannot pursue the company in the wider Pennsylvania federal court multidistrict litigation because the Swiss firm is too far removed from its Sandoz Inc. subsidiary.
-
March 04, 2026
FERC Can't Justify Nixing Grid-Planning Change, DC Circ. Told
The Federal Energy Regulatory Commission failed to justify its rejection of a PJM Interconnection plan to make grid-planning decisions without the approval of the regional grid operator's members committee, transmission owners told the D.C. Circuit on Tuesday.
-
March 04, 2026
Buyers Finalize $58M Generic-Pricing Deal With 3 Drugmakers
Purchasers of certain generic drugs asked a Pennsylvania federal court for final approval of settlements worth a total of at least $58 million with Glenmark Pharmaceutical Inc., Greenstone LLC and Pfizer Inc. over claims the companies colluded with others to keep drug prices high.
-
March 04, 2026
Philly To Pay $750K, Revamp 'Courtesy Towing' Policies
The city of Philadelphia has agreed to pay $750,000 to resolve class claims over its "courtesy towing" program, which involves moving legally parked vehicles to other spots where they could be lost or subject to fines, according to a settlement agreement.
-
March 04, 2026
Supreme Court Rejects NJ Immunity Defense In NY, Pa. Suits
The U.S. Supreme Court ruled Wednesday that New Jersey cannot shield its public transit system from personal injury lawsuits by out-of-state plaintiffs under the doctrine of sovereign immunity.
-
March 03, 2026
Feds, State AGs And Biz Groups Back Monsanto At High Court
The federal government, 15 state attorneys general and business groups, among others, urged the U.S. Supreme Court on Monday to strike down a $1.25 million verdict in a suit over claims Monsanto's Roundup weed killer causes cancer, saying that "patchwork" labeling regulations would harm the nation's farmers.
-
March 03, 2026
Ex-FDA Leaders Rebut Contraception Rollbacks At 3rd Circ.
Former FDA commissioners argued that Trump-era religious exemptions for birth control coverage jeopardize public health and distort medical science, in an animus brief filed Monday with the Third Circuit.
-
March 03, 2026
Khalil Contests Immigration Judge's Removal Order
Former Columbia University graduate student Mahmoud Khalil urged the Board of Immigration Appeals to overturn an immigration judge's allegedly improper determination that he can be removed for purported misrepresentations on a green-card application.
-
March 03, 2026
Man Gets 6 Years In Prison For $5.6M Fraud
A Pennsylvania man who pled guilty to wire fraud and money laundering was sentenced Tuesday in Colorado federal court to more than six years in prison for his role in two separate schemes that defrauded several government entities and individuals of more than $5.6 million.
-
March 03, 2026
Philadelphia Nonprofit Sued Over Employee Info Hack
The Philadelphia Corporation for Aging has been hit with privacy claims by a prospective class of employees alleging the nonprofit's failure to properly safeguard their confidential information might have led to it being stolen by cybercriminals during a data breach in July.
-
March 03, 2026
3rd Circ. Upholds Dismissal Of $800K Union Pension Suit
A split Third Circuit panel said Tuesday it won't revive allegations that two companies owe about $800,000 to a union pension fund, ruling that a New Jersey federal judge properly tossed the claim because the fund waited eight years to tell the companies they owed the money.
-
March 03, 2026
Judge Won't Rely On DOJ 'Decency' In Trans Records Case
A Pennsylvania federal judge blocked the U.S. Department of Justice from getting patient-specific records of gender-affirming care at the University of Pittsburgh Medical Center Children's Hospital, excoriating the government's request and its reasoning for demanding the data.
-
March 03, 2026
Live Nation Tells Jury It's A 'Fierce' But Legal Competitor
Live Nation does not illegally pressure concert venues or artists to use Ticketmaster and its other services, its counsel told a Manhattan federal jury Tuesday, calling the entertainment giant a "fierce, lawful, legitimate" competitor as a closely watched antitrust trial opened.
Expert Analysis
-
Series
Law School's Missed Lessons: Practicing Resilience
Resilience is a skill acquired through daily practices that focus on learning from missteps, recovering quickly without internalizing defeat and moving forward with intention, says Nicholas Meza at Quarles & Brady.
-
Takeaways From The DOJ Fraud Section's 2025 Year In Review
Former acting Principal Deputy Chief Sean Tonolli of the U.S. Department of Justice's Fraud Section, now at Cahill Gordon, analyzes key findings from the section’s annual report — including the changes implemented to adapt to the new administration’s priorities — and lays out what to watch for this year.
-
NYC Bar Opinion Warns Attys On Use Of AI Recording Tools
Attorneys who use artificial intelligence tools to record, transcribe and summarize conversations with clients should heed the New York City Bar Association’s recent opinion addressing the legal and ethical risks posed by such tools, and follow several best practices to avoid violating the Rules of Professional Conduct, say attorneys at Smith Gambrell.
-
Series
The Biz Court Digest: Dispatches From Utah's Newest Court
While a robust body of law hasn't yet developed since the Utah Business and Chancery Court's founding in October 2024, the number of cases filed there has recently picked up, and its existence illustrates Utah's desire to be top of mind for businesses across the country, says Evan Strassberg at Michael Best.
-
4 Quick Emotional Resets For Lawyers With Conflict Fatigue
Though the emotional wear and tear of legal work can trap attorneys in conflict fatigue — leaving them unable to shake off tense interactions or return to a calm baseline — simple therapeutic techniques for resetting the nervous system can help break the cycle, says Chantel Cohen at CWC Coaching & Therapy.
-
Series
Playing Tennis Makes Me A Better Lawyer
An instinct to turn pain into purpose meant frequent trips to the tennis court, where learning to move ahead one point at a time was a lesson that also applied to the steep learning curve of patent prosecution law, says Daniel Henry at Marshall Gerstein.
-
How FERC Is Shaping The Future Of Data Center Grid Use
Two recent orders from the Federal Energy Regulatory Commission affecting the PJM Interconnection and Southwest Power Pool regions offer the first glimpse into how FERC will address the challenges of balancing resource adequacy, grid reliability and fair cost allocation for expansions to accommodate artificial intelligence-driven data centers, say attorneys at Husch Blackwell.
-
And Now A Word From The Panel: MDL Year In Review
2025 was a roller coaster for the Judicial Panel on Multidistrict Litigation, with the panel canceling one hearing session due to the absence of new MDL petitions, yet also issuing rulings on more new MDL petitions than in 2024 — making it clear that MDLs are still thriving, says Alan Rothman at Sidley Austin.
-
Series
Judges On AI: How Judicial Use Informs Guardrails
U.S. Magistrate Judge Maritza Dominguez Braswell at the U.S. District Court for the District of Colorado discusses why having a sense of how generative AI tools behave, where they add value, where they introduce risk and how they are reshaping the practice of law is key for today's judges.
-
Justices' Med Mal Ruling May Spur Huge Shift For Litigators
The U.S. Supreme Court’s recent decision in the medical malpractice suit Berk v. Choy, holding that a Florida procedural requirement does not apply to medical malpractice claims filed in federal court, is likely to encourage eligible parties to file claims in federal court, speed the adjudicatory process and create both opportunities and challenges for litigators, says Thomas Kroeger at Colson Hicks.
-
State Of Insurance: Q4 Notes From Pennsylvania
Last quarter in Pennsylvania, a Superior Court ruling underscored the centrality of careful policy drafting and judicial scrutiny of exclusionary language, and another provided practical guidance on the calculation of attorney fees and interest in bad faith cases, while a proposed bill endeavored to cover insurance gaps for homeowners, says Todd Leon at Marshall Dennehey.
-
Series
Adapting To Private Practice: 5 Tips From Ex-SEC Unit Chief
My move to private practice has reaffirmed my belief in the value of adaptability, collaboration and strategic thinking — qualities that are essential not only for successful client outcomes, but also for sustained professional satisfaction, says Dabney O’Riordan at Fried Frank.
-
Series
Law School's Missed Lessons: How To Start A Law Firm
Launching and sustaining a law firm requires skills most law schools don't teach, but every lawyer should understand a few core principles that can make the leap calculated rather than reckless, says Sam Katz at Athlaw.
-
Justices' Med Mal Ruling May Hurt Federal Anti-SLAPP Suits
The U.S. Supreme Court's recent decision in Berk v. Choy restricts the application of certain state laws in diversity actions in federal court — and while the ruling concerned affidavit requirements in medical malpractice suits, it may also affect the use of anti-SLAPP statutes in federal litigation, says Travis Chance at Brownstein Hyatt.
-
Key False Claims Act Trends From The Last Year
The False Claims Act remains a powerful enforcement tool after some record verdicts and settlements in 2025, and while traditional fraud areas remain a priority, new initiatives are raising questions about its expanding application, says Veronica Nannis at Joseph Greenwald.